Literature DB >> 12471591

Cystic Fibrosis and Burkholderia pseudomallei Infection: An Emerging Problem?

David James Holland1, Alison Wesley, Dragana Drinkovic, Bart J Currie.   

Abstract

We recently managed 4 patients with cystic fibrosis who had acquired Burkholderia pseudomallei infection after exposure in a region of endemicity. Person-to-person transmission between 2 siblings may have occurred; otherwise, the evidence suggests that cystic fibrosis may increase the likelihood of infection with this organism, and patients should be warned of this possibility and cautioned to avoid high-risk activities.

Entities:  

Mesh:

Year:  2002        PMID: 12471591     DOI: 10.1086/344447

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  21 in total

Review 1.  Clinical significance of microbial infection and adaptation in cystic fibrosis.

Authors:  Alan R Hauser; Manu Jain; Maskit Bar-Meir; Susanna A McColley
Journal:  Clin Microbiol Rev       Date:  2011-01       Impact factor: 26.132

Review 2.  Melioidosis: epidemiology, pathophysiology, and management.

Authors:  Allen C Cheng; Bart J Currie
Journal:  Clin Microbiol Rev       Date:  2005-04       Impact factor: 26.132

3.  The epidemiology and clinical spectrum of melioidosis: 540 cases from the 20 year Darwin prospective study.

Authors:  Bart J Currie; Linda Ward; Allen C Cheng
Journal:  PLoS Negl Trop Dis       Date:  2010-11-30

4.  Assessment of fluorescent in situ hybridization and PCR-based methods for rapid identification of Burkholderia cepacia complex organisms directly from sputum samples.

Authors:  A R Brown; J R W Govan
Journal:  J Clin Microbiol       Date:  2007-04-25       Impact factor: 5.948

5.  Cystic fibrosis patient with Burkholderia pseudomallei infection acquired in Brazil.

Authors:  Afonso Luís Barth; Fernando Antonio de Abreu E Silva; Anneliese Hoffmann; Maria Izolete Vieira; Alexandre Prehn Zavascki; Alex Guerra Ferreira; Luiz Gonzaga da Cunha; Rodolpho Mattos Albano; Elizabeth de Andrade Marques
Journal:  J Clin Microbiol       Date:  2007-10-17       Impact factor: 5.948

6.  Burkholderia pseudomallei infection in a cystic fibrosis patient from the Caribbean: a case report.

Authors:  Dimas Mateos Corral; Allan L Coates; Yvonne C W Yau; Raymond Tellier; Mindy Glass; Steven M Jones; Valerie J Waters
Journal:  Can Respir J       Date:  2008 Jul-Aug       Impact factor: 2.409

7.  Burkholderia pseudomallei: another emerging pathogen in cystic fibrosis.

Authors:  M R O'Carroll; T J Kidd; C Coulter; H V Smith; B R Rose; C Harbour; S C Bell
Journal:  Thorax       Date:  2003-12       Impact factor: 9.139

8.  Burkholderia pseudomallei in cystic fibrosis and treatment complications.

Authors:  Naghmeh Radhakrishna; Judith Morton
Journal:  Respirol Case Rep       Date:  2014-11-30

9.  Rapid identification of Burkholderia mallei and Burkholderia pseudomallei by intact cell Matrix-assisted Laser Desorption/Ionisation mass spectrometric typing.

Authors:  Axel Karger; Rüdiger Stock; Mario Ziller; Mandy C Elschner; Barbara Bettin; Falk Melzer; Thomas Maier; Markus Kostrzewa; Holger C Scholz; Heinrich Neubauer; Herbert Tomaso
Journal:  BMC Microbiol       Date:  2012-10-10       Impact factor: 3.605

10.  An international, multicentre evaluation and description of Burkholderia pseudomallei infection in cystic fibrosis.

Authors:  James B Geake; David W Reid; Bart J Currie; Scott C Bell; Rowland Bright-Thomas; Jane Dewar; Steve Holden; Nicholas Simmonds; Khin Gyi; Dervla Kenna; Valerie Waters; Mary Jackson; Brian O'Sullivan; Giovanni Taccetti; John Kolbe; Mark O'Carroll; Dee Campbell; Mirjana Jaksic; Naghmeh Radhakrishna; Timothy J Kidd; William Flight
Journal:  BMC Pulm Med       Date:  2015-10-09       Impact factor: 3.317

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.